Clostridium bacteria are a large genus of gram-positive, rod-shaped, and anaerobic bacteria. There are over 100 species of Clostridium, some of which can cause illness in humans and animals. Several Clostridium species release toxins that cause damage to tissues and organs. Some of the more important disease-causing Clostridium species include C. tetani, C. botulinum, C. perfringens, and C. difficile.
Clostridium tetani
C. tetani bacteria are found in soil and dust. When their spores enter a wound, the spores can germinate and release a potent neurotoxin called tetanus toxin. The toxin causes muscle spasms and stiffness, as it inhibits the release of neurotransmitters that allow muscles to relax. Left untreated, tetanus infection can cause death by respiratory failure. Clostridium Vaccine have reduced the number of tetanus cases by over 95% globally.
Clostridium botulinum
C. botulinum bacteria produce the most potent neurotoxin known, botulinum toxin. Ingesting pre-formed botulinum toxin in improperly canned, bottled or processed foods can cause botulism, a type of food poisoning. Symptoms include blurred or double vision, drooping eyelids, slurred speech, trouble swallowing, and muscle weakness throughout the body. Very large toxin doses can cause respiratory failure leading to death. There is no vaccine for botulism though antitoxins given early in treatment can help. Food safety practices aim to prevent growth and toxin production by C. botulinum.
Clostridium perfringens
C. perfringens is a common cause of food poisoning in developed countries. It produces numerous toxins and enzymes. When large numbers of the bacteria are swallowed from contaminated foods, an enterotoxin it produces causes abdominal cramps and diarrhea. However, some C. perfringens strains can also cause gas gangrene or myonecrosis - life-threatening necrotizing infections of muscles and soft tissues. No vaccine exists for C. perfringens food poisoning or gas gangrene. Antibiotics are used to treat infections.
Clostridium difficile
C. difficile usually does not cause illness in healthy people as other bacteria in the gut normally prevent C. difficile from multiplying excessively. However, when antibiotic use disrupts the normal gut flora, C. difficile can overgrow and produce toxins A and B which cause symptoms ranging from diarrhea to potentially fatal pseudomembranous colitis. Risk factors for C. difficile infection include antibiotic use, advanced age, and hospitalization. While fecal microbiota transplantation can cure recurrent C. difficile infections, there is no vaccine against this bacterium yet. Antibiotics together with toxin-binding drugs are used to treat infections.
Available Clostridium vaccines
Clostridium tetani vaccine
The tetanus vaccine (also known as the tetanus toxoid) contains inactivated/denatured tetanus toxin from C. tetani. When administered according to recommended schedules, it induces protective antibodies against the tetanus toxin in the bloodstream and prevents the disease from developing in the event of a wound contaminated with C. tetani spores. Booster doses every 10 years sustain immunity. The vaccine is very effective and is routinely given to all infants and children in combination with diphtheria and pertussis vaccines.
Potential Clostridium vaccines under development
Experimental C. difficile vaccine
Researchers are developing C. difficile vaccines that target the surface layer proteins, toxins, or a combination of both to induce protective immunity. Phase II and III clinical trials of various vaccine candidates containing surface layer proteins and toxoids have shown success in stimulating antibody responses and preventing recurrence of C. difficile infections. In the future, vaccination may help high risk groups such as the elderly and hospitalized patients by boosting their defenses against C. difficile. However, more clinical testing is still needed before these vaccines can be approved.
Challenges of developing Clostridium vaccines
Complex toxin structure and function
The potent and complex activity of clostridial toxins makes them difficult targets for vaccination. Understanding how to inactivate or attenuate the toxicity while still inducing strong and long-lasting immunity poses a challenge.
Variable strains and toxin subtypes
C. botulinum and C. perfringens have several toxin subtypes, while C. difficile clinical isolates vary greatly in their surface proteins. This makes it difficult to develop multivalent vaccines that are broadly protective against all strains that cause disease.
Hypersporulation issues
Developing vaccines against clostridial spores may spur unwanted spore overproduction by the pathogen in response to immune stimulation. More research is still needed on this phenomenon to create safe and effective spore vaccines.
Tetanus vaccine has proven effective at preventing tetanus caused by C. tetani infection. Research continues on developing vaccines for other diseases caused by Clostridium species like botulism, gas gangrene and C. difficile infections. Overcoming the complex toxin actions and variable strains presents hurdles. With further development, Clostridium vaccines show promise to help control additional serious bacterial infections.
Get more insights on Clostridium Vaccine
Comments
0 comment